Exact Mass: 506.2893
Exact Mass Matches: 506.2893
Found 500 metabolites which its exact mass value is equals to given mass value 506.2893
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea. (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of leaves of Camellia sinensis var. sinensis (China tea). Constituent of leaves of Camellia sinensis variety sinensis (China tea). (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea.
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is found in fruits. (5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is a constituent of Physalis peruviana (Cape gooseberry). Constituent of Physalis peruviana (Cape gooseberry). (5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is found in fruits.
Ixabepilone
Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a cancer drug. On October 16, 2007, the U.S. Food and Drug Administration approved ixabepilone for the treatment of aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies. Ixabepilone is administered through injection, and will be marketed under the trade name Ixempra. [Wikipedia] Ixabepilone is a semisynthetic analogue of epothilone B. It has a lactone lactam modification that
Bemcentinib
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Chromogenic Substrate S-2266
(3R,9S)-megastigman-5-en-3,9-diol 3-O-[alpha-L-arabinofuranosyl-(1->6)]-beta-D-glucopyranoside
11-O-acetyl-12-O-isovaleroyl-17beta-marsdenin|8-hydroxydrevogenin A
(1R,2E,4S,5R,6S,7E,10S,11S,12R)-5,6,10,18-tetraacetoxy-2,7-dolabelladiene|5,6,10,18-Tetraacetoxy-2,7-dolabelladiene
6alpha-O-(6-O-acetyl-beta-D-glucopyranosyl)-15,16-epoxycleroda-3,13(16),14-triene|salvigreside D
6beta-cinnamoyloxy-7beta-acetoxyvouacapen-5alpha-ol
(20S,22R,24S,25R)-5alpha,6beta,14alpha,17beta,20-pentahydroxy-1-oxowitha-2-en-22,26-olide|24,25-dihydrowithanolide S
(2S)-2,3,9,10-tetrahydro-2-[3,4-dihydro-8-(3-ethoxy-3-methylbutyl)-2,2-dimethyl-2H-chromen-6-yl]-8,8-dimethyl-4H,8H-pyrano[2,3-f]chromen-4-one|tonkinochromane E
(2E)-3-[3,4-dihydro-8-(3-ethoxy-3-methylbutyl)-2,2-dimethyl-2H-chromen-6-yl]-1-(3,4-dihydro-5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one|tonkinochromane F
7-megastigmen-3-ol-9-one 3-O-alpha-L-arabinofuranosyl-(1?6)-beta-D-glucopyranoside
3beta,4beta,5alpha,6beta,27-pentahydroxy-1-oxo-with-24-enolide
digitoxigenin-3-O-beta-d-xyloside|digitoxigenyl beta-D-xyloside
(2R,9R)-megastigman-5-en-2,9-diol 9-O-alpha-L-arabinopyranosyl(1->6)-beta-D-glucopyranoside|foliasalacioside I
14-O-alpha-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid
Asn Val Phe Lys
Phe Val Ile Glu
Asn Phe Ala Arg
C30H38N2O5_(1E)-6-Hydroxy-12-(1H-indol-3-ylmethyl)-7-methoxy-4,13,13a-trimethyl-5,6,7,8,12,12a,13,13a,14a,14b-decahydro-3H-cycloundeca[d]oxireno[f]isoindole-9,10(4H,11H)-dione
C24H42O11_beta-D-Glucopyranoside, (1S,4R,5R)-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,3,5-trimethylcyclohexyl 6-O-[(2R,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
Ala Phe Asn Arg
Ala Phe Arg Asn
Ala Asn Phe Arg
Ala Asn Arg Phe
Ala Arg Phe Asn
Ala Arg Asn Phe
Cys Lys Arg Thr
Cys Lys Thr Arg
Cys Arg Lys Thr
Cys Arg Thr Lys
Cys Thr Lys Arg
Cys Thr Arg Lys
Asp Phe Ile Ile
Asp Phe Ile Leu
Asp Phe Leu Ile
Asp Phe Leu Leu
Asp Ile Phe Ile
Asp Ile Phe Leu
Asp Ile Ile Phe
Asp Ile Leu Phe
Asp Leu Phe Ile
Asp Leu Phe Leu
Asp Leu Ile Phe
Asp Leu Leu Phe
Glu Phe Ile Val
Glu Phe Leu Val
Glu Phe Val Ile
Glu Phe Val Leu
Glu Ile Phe Val
Glu Ile Val Phe
Glu Leu Phe Val
Glu Leu Val Phe
Glu Val Phe Ile
Glu Val Phe Leu
Glu Val Ile Phe
Glu Val Leu Phe
Phe Ala Asn Arg
Phe Ala Arg Asn
Phe Asp Ile Ile
Phe Asp Ile Leu
Phe Asp Leu Ile
Phe Asp Leu Leu
Phe Glu Ile Val
Phe Glu Leu Val
Phe Glu Val Ile
Phe Glu Val Leu
Phe Gly Lys Arg
Phe Gly Gln Arg
Phe Gly Arg Lys
Phe Gly Arg Gln
Phe Ile Asp Ile
Phe Ile Asp Leu
Phe Ile Glu Val
Phe Ile Ile Asp
Phe Ile Leu Asp
Phe Ile Val Glu
Phe Lys Gly Arg
Phe Lys Asn Val
Phe Lys Arg Gly
Phe Lys Val Asn
Phe Leu Asp Ile
Phe Leu Asp Leu
Phe Leu Glu Val
Phe Leu Ile Asp
Phe Leu Leu Asp
Phe Leu Val Glu
Phe Asn Ala Arg
Phe Asn Lys Val
Phe Asn Arg Ala
Phe Asn Val Lys
Phe Gln Gly Arg
Phe Gln Arg Gly
Phe Arg Ala Asn
Phe Arg Gly Lys
Phe Arg Gly Gln
Phe Arg Lys Gly
Phe Arg Asn Ala
Phe Arg Gln Gly
Phe Val Glu Ile
Phe Val Glu Leu
Phe Val Lys Asn
Phe Val Leu Glu
Phe Val Asn Lys
Gly Phe Lys Arg
Gly Phe Gln Arg
Gly Phe Arg Lys
Gly Phe Arg Gln
Gly Lys Phe Arg
Gly Lys Arg Phe
Gly Gln Phe Arg
Gly Arg Phe Lys
Gly Arg Lys Phe
Ile Asp Phe Ile
Ile Asp Phe Leu
Ile Asp Ile Phe
Ile Asp Leu Phe
Ile Glu Phe Val
Ile Glu Val Phe
Ile Phe Asp Ile
Ile Phe Asp Leu
Ile Phe Glu Val
Ile Phe Ile Asp
Ile Phe Leu Asp
Ile Phe Val Glu
Ile Ile Asp Phe
Ile Ile Phe Asp
Ile Ile Val Tyr
Ile Ile Tyr Val
Ile Leu Asp Phe
Ile Leu Phe Asp
Ile Leu Val Tyr
Ile Leu Tyr Val
Ile Val Glu Phe
Ile Val Phe Glu
Ile Val Ile Tyr
Ile Val Leu Tyr
Ile Val Tyr Ile
Ile Val Tyr Leu
Ile Tyr Ile Val
Ile Tyr Leu Val
Ile Tyr Val Ile
Ile Tyr Val Leu
Lys Cys Arg Thr
Lys Cys Thr Arg
Lys Phe Gly Arg
Lys Phe Asn Val
Lys Phe Arg Gly
Lys Phe Val Asn
Lys Gly Phe Arg
Lys Gly Arg Phe
Lys Lys Met Thr
Lys Lys Thr Met
Lys Met Lys Thr
Lys Met Thr Lys
Lys Asn Phe Val
Lys Asn Val Phe
Lys Arg Cys Thr
Lys Arg Phe Gly
Lys Arg Gly Phe
Lys Arg Thr Cys
Lys Thr Cys Arg
Lys Thr Lys Met
Lys Thr Met Lys
Lys Thr Arg Cys
Lys Val Phe Asn
Lys Val Asn Phe
Leu Asp Phe Ile
Leu Asp Phe Leu
Leu Asp Ile Phe
Leu Asp Leu Phe
Leu Glu Phe Val
Leu Glu Val Phe
Leu Phe Asp Ile
Leu Phe Asp Leu
Leu Phe Glu Val
Leu Phe Ile Asp
Leu Phe Leu Asp
Leu Phe Val Glu
Leu Ile Asp Phe
Leu Ile Phe Asp
Leu Ile Val Tyr
Leu Ile Tyr Val
Leu Leu Asp Phe
Leu Leu Phe Asp
Leu Leu Val Tyr
Leu Leu Tyr Val
Leu Val Glu Phe
Leu Val Phe Glu
Leu Val Ile Tyr
Leu Val Leu Tyr
Leu Val Tyr Ile
Leu Val Tyr Leu
Leu Tyr Ile Val
Leu Tyr Leu Val
Leu Tyr Val Ile
Leu Tyr Val Leu
Met Lys Lys Thr
Met Lys Thr Lys
Met Thr Lys Lys
Asn Phe Lys Val
Asn Phe Val Lys
Asn Lys Phe Val
Asn Lys Val Phe
Asn Val Lys Phe
Arg Cys Lys Thr
Arg Cys Thr Lys
Arg Phe Gly Lys
Arg Phe Lys Gly
Arg Gly Phe Lys
Arg Gly Lys Phe
Arg Lys Cys Thr
Arg Lys Phe Gly
Arg Lys Gly Phe
Arg Lys Thr Cys
Arg Thr Cys Lys
Arg Thr Lys Cys
Thr Cys Lys Arg
Thr Cys Arg Lys
Thr Lys Cys Arg
Thr Lys Lys Met
Thr Lys Met Lys
Thr Lys Arg Cys
Thr Met Lys Lys
Thr Arg Cys Lys
Thr Arg Lys Cys
Val Glu Phe Ile
Val Glu Phe Leu
Val Glu Ile Phe
Val Glu Leu Phe
Val Phe Glu Ile
Val Phe Glu Leu
Val Phe Ile Glu
Val Phe Lys Asn
Val Phe Leu Glu
Val Phe Asn Lys
Val Ile Glu Phe
Val Ile Phe Glu
Val Ile Ile Tyr
Val Ile Leu Tyr
Val Ile Tyr Ile
Val Ile Tyr Leu
Val Lys Phe Asn
Val Lys Asn Phe
Val Leu Glu Phe
Val Leu Phe Glu
Val Leu Ile Tyr
Val Leu Leu Tyr
Val Leu Tyr Ile
Val Leu Tyr Leu
Val Asn Phe Lys
Val Asn Lys Phe
Val Tyr Ile Ile
Val Tyr Ile Leu
Val Tyr Leu Ile
Val Tyr Leu Leu
Tyr Ile Ile Val
Tyr Ile Leu Val
Tyr Ile Val Ile
Tyr Ile Val Leu
Tyr Leu Ile Val
Tyr Leu Leu Val
Tyr Leu Val Ile
Tyr Leu Val Leu
Tyr Val Ile Ile
Tyr Val Ile Leu
Tyr Val Leu Ile
Tyr Val Leu Leu
(5Z,7E,22E)-(3S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19),22-cholestatetraene-3,25-diol
Ixabepilone
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
14-O-(alpha-L-rhamnopyranosyl)-7S,14R-dihydroxy-7,9,13,17-tetramethyl-2E,4E,8E,10E,12E,16E-octadecahexaenoic acid
(E)-12-((1H-indol-3-yl)methyl)-6-hydroxy-7-methoxy-4,13,13a-trimethyl-3,5,6,7,8,11,12,12a,13,13a,14a,14b-dodecahydro-9H-cycloundeca[d]oxireno[2,3-f]isoindole-9,10(4H)-dione
(22E)-26,26,26,27,27,27-hexafluoro-25-hydroxy-22,23-didehydrovitamin D3
2,3-Bis[(1-oxooctyl)oxy]propyl beta-D-galactopyranoside
Bemcentinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
1,2-Dioctanoyl-3-beta-d-galactosyl-sn-glycerol
A 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as octanoyl.
Ile-Leu-Val-Tyr
A tetrapeptide composed of L-isoleucine, L-leucine, L-valine and L-tyrosine joined in sequence by peptide linkages.
8-[1-[4-(Dimethylamino)phenyl]-3-(1-pyrrolidinyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one
1-Hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3-phosphate
(1R)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
[2-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] octanoate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate
[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] decanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-nonadec-9-enoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tridec-9-enoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetradec-9-enoate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phospho-(1-sn-glycerol)
(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-(2-methyl-4-thiazolyl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
2-[(1r,3ar,6r,7r,8r,12s,12as)-7,8,12-tris(acetyloxy)-3a,6,10-trimethyl-1h,2h,3h,6h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-1-yl]propan-2-yl acetate
(2e,4e,7s,8e,10e,12e,14r)-7-hydroxy-7,9,13,17-tetramethyl-14-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}octadeca-2,4,8,10,12,16-hexaenoic acid
3-[8-(3-ethoxy-3-methylbutyl)-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]-1-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-en-1-one
(2r,3r,5r,6r,8s,9s,10r,11r)-8,10-dihydroxy-3,5,9,11-tetramethyl-2-[(2r)-3-oxopentan-2-yl]-8-[(1s)-1-(3,5,6-trimethyl-4-oxopyran-2-yl)ethyl]-1,7-dioxaspiro[5.5]undecan-4-one
3-{[(1r,9r,13e)-13-ethylidene-5-hydroxy-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-1-yl]amino}-3a,5-dihydroxy-6,8,8-trimethyl-3h,4h,5h,6h,6ah,7h,9h-azuleno[4,5-c]furan-1-one
(2s,3r,4s,5s,6r)-2-{[(1r)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(3z,3as,5ar,7s,9ar,9bs)-3a,6,6,9a-tetramethyl-3-[(3e,5z)-6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-2-oxo-octahydrocyclopenta[a]naphthalen-7-yl acetate
6-(1-{3a,5,5a-trihydroxy-9a,11a-dimethyl-9-oxo-dodecahydrocyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s,3s)-2-amino-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid
(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(1s)-1-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
(6r)-6-[(1r)-1-[(1s,3ar,3br,5r,5ar,9ar,9br,11ar)-3a,5,5a-trihydroxy-9a,11a-dimethyl-9-oxo-dodecahydrocyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
5-(4,14-dihydroxy-9,13,15-trimethyl-17-phenylheptadeca-1,5,7,9,11-pentaen-1-yl)-2-hydroxy-2,4-dimethylfuran-3-one
16-isopropyl-4,10,13,19-tetramethyl-3,8,17-trioxo-7-(propan-2-ylidene)pentacyclo[10.7.1.0¹,¹⁴.0²,¹¹.0⁵,¹¹]icosa-4,13-dien-20-yl acetate
15-(acetyloxy)-2-[2-(acetyloxy)ethylidene]-10-[(acetyloxy)methyl]-6,14-dimethylpentadeca-5,9,13-trien-1-yl acetate
2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[4-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1r)-4-[(3s)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}oxane-3,4,5-triol
(5s,7r,8r,10r,11r,12r,15r,16s,18z,25s)-11-acetyl-2,20-dihydroxy-10,26-dimethyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20-pentaene-27,28-dione
(2r,3r,4s,5r,6r)-2-({[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(4s)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
8,10-dihydroxy-3,5,9,11-tetramethyl-2-(3-oxopentan-2-yl)-8-[1-(3,5,6-trimethyl-4-oxopyran-2-yl)ethyl]-1,7-dioxaspiro[5.5]undecan-4-one
(2r,3r,4s,5s,6r)-2-{[(1s)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(20r,22r)-5α,6β,14α,20,27-pentahydroxy-1-oxowitha-24-enolide
{"Ingredient_id": "HBIN003440","Ingredient_name": "(20r,22r)-5\u03b1,6\u03b2,14\u03b1,20,27-pentahydroxy-1-oxowitha-24-enolide","Alias": "NA","Ingredient_formula": "C28H42O8","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C(C)(C2CCC3(C2(CCC4C3CC(C5(C4(C(=O)CCC5)C)O)O)C)O)O)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16845","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,9s)-megastigman-5-en-3,9-diol-3-o-[α-l-arabinofuranosyl-(1→6)]-β-d-glucopyranoside
{"Ingredient_id": "HBIN009576","Ingredient_name": "(3r,9s)-megastigman-5-en-3,9-diol-3-o-[\u03b1-l-arabinofuranosyl-(1\u21926)]-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C24H42O11","Ingredient_Smile": "CC1=C(C(CC(C1)OC2C(C(C(C(O2)COC3C(C(C(O3)CO)O)O)O)O)O)(C)C)CCC(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13635","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}